Invuity, a San Francisco, CA-based developer of surgical visualization and illumination technology, has closed a $25m Series D financing.
The round was led by Valence Advantage Life Sciences Fund II, with participation from Kleiner Perkins Caufield & Byers, InterWest Partners, and Wexford Capital.
The company intends to use the funding to expand development, manufacturing and commercialization efforts for its medical devices.
Led by CEO Philip Sawyer, Invuity develops medical devices to improve visualization in minimally invasive surgeries. Its products incorporate its proprietary Eigr™ illumination technology into advanced access systems for a variety of surgical specialties.
In conjunction with the funding, Eric Roberts from Valence Advantage will join the company’s Board of Directors.